Cipla Limited (CIPLA) announces a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to Keytruda® in the US.
Biocon Limited (BIOCON) reports a 9% rise in total income to Rs 4,391 Cr for Q1 FY27, driven by strong Biopharma growth.
Emcure Pharmaceuticals Limited consolidates Gennova ownership, sharpens focus on biologics; Samit Mehta leads next phase of growth.